Syngenta posts higher Q3 2025 earnings despite lower sales

Syngenta Group reported a 28% increase in third-quarter EBITDA to $0.9 billion despite a 6% decline in sales to $6.4 billion, as profitability improvements in core businesses offset lower revenues. At constant exchange rates (CER), EBITDA rose 35%, while sales were down 7%.

For the first nine months of 2025, sales reached $20.9 billion, 2% lower than the same period last year (-1% at CER). EBITDA for the nine-month period climbed 25% to $3.4 billion (+31% at CER), bringing the group’s EBITDA margin to 16.5%, up from 12.9% a year earlier. The company attributed the revenue decline mainly to a managed reduction in its grain trading business in China.

Syngenta said its focus on research and development, cost discipline, and operational efficiency continued to strengthen margins across most business segments, particularly in crop protection. The group expects stable sales and further profitability gains in the final quarter of 2025, although it warned that farmer profitability remains under pressure globally.

Crop protection growth and biologicals momentum

Sales in the Crop Protection division rose 3% to $9.8 billion in the first nine months of the year (+5% at CER), driven by volume growth across most regions despite pricing pressures. Europe and Asia, the Middle East and Africa (excluding China) each posted 6% sales growth, while China advanced 7%. North America increased 3%, and Brazil 2%, supported by strong uptake of PLINAZOLIN technology. However, drought in Mexico and price pressure in Argentina contributed to a 7% sales decline across Latin America.

The biologicals segment maintained strong momentum with double-digit growth. Syngenta Crop Protection secured over 1,200 product approvals so far in 2025, including launches of SEGURIS Evo and VESTORIA Pro in rice, and further global expansion of ADEPIDYN and TYMIRIUM technologies.

Seeds rebound in Latin America

Syngenta Seeds posted $3.3 billion in sales for the first nine months, up 1% year-on-year (+2% CER). Field crops in Latin America rose 20%, led by a strong recovery in Argentina’s corn market and solid demand in Brazil. Vegetable Seeds grew 3%, while Flower sales were slightly lower.

The Seeds business advanced AI integration in its R&D pipeline and introduced new hybrid crop varieties across regions, including X-TERRA wheat in Europe and hybrid rice in Indonesia and Vietnam. In China, Syngenta’s seed unit was named among Fortune’s “China Top 50 Tech Companies” for 2025.

Syngenta Group China and ADAMA results

Syngenta Group China reported $6.5 billion in sales, down 11% year-on-year due to the planned reduction of its grain trading business. Excluding that segment, Seeds, Branded Formulations, and Crop Nutrition achieved growth between 4% and 6%. Yangnong Chemical sales rose 14%.

ADAMA maintained stable sales of $3.0 billion during the period, marking its sixth consecutive quarter of EBITDA growth under the “Fight Forward” transformation plan. North American sales grew 15%, offsetting weaker performance in Latin America and Asia-Pacific.

Syngenta said ADAMA continues to prioritize portfolio quality and innovation, highlighting new product launches such as FERRABAIT and COSAYR, and its first European registration of an Aminopyralid-based formulation under the name PORAFAM.

The group reaffirmed its commitment to profitability and innovation across business lines while navigating a challenging global agricultural environment.